Living reference work entry
This compound acts against HAT (human African trypanosomiasis) and is now used (2014) in clinical trials of phase III.
KeywordsClinical Trial Human African Trypanosomiasis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Springer-Verlag Berlin Heidelberg 2015